Britain | EUROPESAYS.COM
  • /
  • Europe
  • France
  • Spain
  • Canada
  • Australia
  • Africa
  • Football
  • Tennis
  • Golf
  • PM
  • England
    • London
    • Cambridgeshire
    • Cumbria
    • Derbyshire
    • Devon
    • Dorset
    • East Sussex
    • Essex
    • Gloucestershire
    • Hampshire
    • Hertfordshire
  • Britain
  • …
    • Germany
    • Italy
    • Ukraine
    • Poland
    • Netherlands
    • Russia
    • Iran
    • Japan
    • AI
  • @
  • AstraZeneca
  • BAE Systems
  • Barclays
  • BP
  • Britain
  • British American Tobacco
  • Compass Group
  • Diageo
  • Glencore
  • GSK
  • HSBC
  • Lloyds Banking Group
  • London
  • London Stock Exchange Group
  • National Grid
  • NatWest
  • Reckitt Benckiser
  • Rio Tinto
  • Rolls-Royce
  • Shell
  • Standard Chartered
  • UK
  • Unilever
Britain | EUROPESAYS.COM
  • /
  • Europe
  • France
  • Spain
  • Canada
  • Australia
  • Africa
  • Football
  • Tennis
  • Golf
  • PM
  • England
    • London
    • Cambridgeshire
    • Cumbria
    • Derbyshire
    • Devon
    • Dorset
    • East Sussex
    • Essex
    • Gloucestershire
    • Hampshire
    • Hertfordshire
  • Britain
  • …
    • Germany
    • Italy
    • Ukraine
    • Poland
    • Netherlands
    • Russia
    • Iran
    • Japan
    • AI
  • @

Browsing Tag

Moderna

4 posts
GGSK
GSK's mRNA flu vaccine data closely tracks Moderna's, Deutsche Bank says
Read More

GSK’s mRNA flu vaccine data closely tracks Moderna’s, Deutsche Bank says

  • September 4, 2026
GSK’s mRNA flu vaccine data closely tracks Moderna’s, Deutsche Bank says Proactive uses images sourced from Shutterstock GSK…
GGSK
Does Moderna's mRNA Flu Shot Face a New Challenge From GSK?
Read More

Does Moderna’s mRNA Flu Shot Face a New Challenge From GSK?

  • September 3, 2026
Moderna MRNA recently secured FDA approval for mFlusiva, the first mRNA-based seasonal flu vaccine. The decision is a…
GGSK
GSK hopes to take on Moderna as it moves mRNA flu vaccine to Phase III trial
Read More

GSK hopes to take on Moderna as it moves mRNA flu vaccine to Phase III trial

  • September 2, 2026
GSK’s seasonal, mRNA-based influenza vaccine is progressing to a Phase III study after securing a safety and efficacy…
GGSK
GSK Advances mRNA Flu Shot to Phase 3 After Beating Standard Vaccines in Mid-Stage Trial — BigGo Finance
Read More

GSK Advances mRNA Flu Shot to Phase 3 After Beating Standard Vaccines in Mid-Stage Trial — BigGo Finance

  • September 2, 2026
GSK is moving its experimental mRNA-based seasonal flu vaccine into a late-stage trial after mid-stage data showed it…
Britain | EUROPESAYS.COM
www.europesays.com